Nitrazepam Accord (Nitrazepam)

Nitrazepam binds to a specific modulatory site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases the frequency with which the associated chloride channel opens in response to GABA, leading to greater neuronal hyperpolarization. The resulting enhanced inhibitory signaling reduces overall central nervous system excitability, producing its hypnotic, anxiolytic, and anticonvulsant effects.

The appropriate dose of Nitrazepam Accord is determined individually by a qualified prescriber based on the patient’s condition, age, response to therapy, and any concurrent medications. Healthcare professionals consider clinical guidelines and patient-specific factors when selecting the strength and frequency of administration. Patients should follow the exact dosing instructions provided on the prescription label.

Safety data for nitrazepam use in pregnancy and lactation are limited, and the drug is generally classified as contraindicated or to be used only when the potential benefit outweighs the risk. Because benzodiazepines can cross the placenta and appear in breast milk, clinicians usually avoid prescribing nitrazepam to pregnant or nursing women unless no suitable alternative exists.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity of Nitrazepam Accord. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements if applicable), and assists with import documentation.

Nitrazepam shares the core mechanism of GABA‑A modulation with other benzodiazepines such as temazepam or lorazepam, but it has a relatively long elimination half‑life, which can provide sustained hypnotic effect useful for sleep maintenance. Compared with shorter‑acting agents, nitrazepam may carry a higher risk of next‑day sedation and accumulation in elderly patients, so clinicians balance efficacy with safety when selecting a specific benzodiazepine.

Nitrazepam Accord should be stored at ambient temperature below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store it in bathrooms or other humid environments. If the tablets become discolored or damaged, discard them according to local regulations and obtain a replacement from a qualified pharmacy.

Nitrazepam Accord is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed, unless a prescriber specifically advises an alternative method. Doses are typically administered once daily at bedtime for insomnia or as directed for anxiety or seizure control. Patients should follow the timing and frequency prescribed by their healthcare provider.

The most serious risks include respiratory depression, especially when combined with other central nervous system depressants, severe skin reactions such as Stevens‑Johnson syndrome, and the potential for physical dependence, tolerance, and withdrawal syndrome upon abrupt discontinuation. Rare but critical events can involve suicidal ideation, profound sedation, and paradoxical reactions like agitation or aggression, which require immediate medical attention.

Nitrazepam should be avoided in individuals with known hypersensitivity to benzodiazepines, severe respiratory insufficiency (e.g., COPD with CO₂ retention), acute narrow‑angle glaucoma, and those with a history of severe hepatic impairment where drug clearance is markedly reduced. Caution is also advised for patients with a personal or family history of substance misuse, as the medication carries a risk of dependence.